ModivCare — Investor Presentation (January 2021)
31 slides from ModivCare's investor presentation, Jan 11, 2021
Slide 1: ModivCare Inc. Investor Presentation January 2021
MODIVCARE INC. INVESTOR PRESENTATION JANUARY 2021 NASDAQ: MODV di “MAKING CONNECTIONS TO CARE”
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS Certain statements contained inthis presentation constitute “forward-looking statements” within the meaning ofthe Private Securities Litigation Reform Act of 1995. hese statements are predictive in nature and are frequently identified by the use ofterms such as "may," “wil
Slide 3: Who Is ModivCare?
WHO IS MODIVCARE? © On January 6, 2021, The Providence Service Corporation and LogistiCare rebranded as ModivCare, to align our entire organization, from our processes to our people, aroundour Year Formed 1996 core purpose — Making Connections to Care. © We provide critical social determinants of Ex
Slide 4: Vision: One-Stop Shop for SDOH Solutions
VISION: ONE-STOP SHOP FOR SDOH SOLUTIONS Simplura Home Nurse Int Telemedicine Hosice Clinical erventions Supaiee Howe calle MODV is one of the largest players in SDOH today with unique technology, risk and data capabilities Combined organization will have platforms across multiple high value segment
Slide 5: New Leadership with a Track Record of Operational Excellence
NEW LEADERSHIP WITH A TRACK RECORD OF OPERATIONAL EXCELLENCE DANIEL E. GREENLEAF KEVIN DOTTS KENNETH WILSON KATHRYN STALMACK PRESIDENT & CEO CHIEF FINANCIAL OFFICER CHIEF OPERATING OFFICER ‘SVP, GENERAL COUNSEL &pscrip ecoram Dp Cudigan. Hanger sodex® bio@scrip Solutions it Homesouicn 9 SEAPRIA £. e
Slide 6: Non-Emergency Medical Transportation
on-Emergency Medical Transportation ModivCare provides non-emergency medical transportation services for members whose limited mobility or financial resources hinders their ability to access necessary healthcare and social services.
Slide 7: NEMT 2019 Revenue Breakdown ($1.5B)
NEMT 2019 REVENUE BREAKDOWN ($1.5B)! 790% ANNUAL RENEWAL RATE By Funding Source By Contract Type By Payor Type 49% Hi Medicaid Hi Capitated Hi MCOs i | Medicare Advantage i | Other ii State Medicaid Agencies Stable non-cyclical Medicaid business Capitated contracts drive Managed Care Organization (“
Slide 8: Launched Six-Pillar Strategy to Drive Transformational Growth
LAUNCHED SIX-PILLAR STRATEGY TO DRIVE TRANSFORMATIONAL GROWTH VOICE OF THE ‘TRANSFORMATIONAL CUSTOMER GROWTH INTHE RIGHT SEATS. Creating a Growing beyond ing each person best-in-class being the largest is in the role that experience for our NEMT provider into a best fits their skills ‘customers and
Slide 9: Clear Market Leader in the U.S. NEMT Industry
CLEAR MARKET LEADER IN THE U.S. NEMT INDUSTRY * ModivCare is more than three Estimated U.S. NEMT Market Share* mod times larger than the #2 player ¢ Nationwide presence © Scale matters — Ability to invest in technology and innovation to enhance customer experience SOUTHEASTRANS y — Transportation pr
Slide 10: NEMT - Large & Growing Addressable Market
NEMT - LARGE & GROWING ADDRESSABLE MARKET Add ~$6B for Adjacent Market Opportunities (e.g., Workers Comp, VA, Food Delivery, Retirees) Add ~$4B for Medicare Advantage Growth (potential benefit expansion and enrollment increases over the next decade) Existing U.S. NEMT Market (est.) ModivCare (2019 r
Slide 11: NEMT - Industry Growth Drivers
NEMT - INDUSTRY GROWTH DRIVERS ¢ Medicaid enrollment increasing an estimated 7-10% near term ¢ Medicare Advantage-eligible beneficiaries expected to increase from 59mm to 80mm by 2030 ¢ Rapidly aging population ¢ Increased emphasis on social determinants of health ¢ Focus on value-based care and out
Slide 12: National MedTrans Acquisition — May 2020
NATIONAL MEDTRANS ACQUISITION — MAY 2020 ¢ Financially Compelling lad - Purchase price: ~$80 million all cash — Gross margin profile in line with ModivCare’s - Annual revenue of >$200 million - ~85% capitated (recurring in nature) — Accretive to earnings © Strategically Compelling — Deepens national
Slide 13: ModivCare's COVID-19 Response
MODIVCARE’S COVID-19 RESPONSE * Our top priority is protecting the health and safety of teammates, transportation partners and members © We have innovated our services to meet evolving needs during the pandemic — Providing members with access to food — Transport of healthcare professionals © We are
Slide 14: Simplura Health Group
SIMPLURA HEALTH GROUP ModivCare’s Simplura subsidiary provides non-medical home care to primarily Medicaid patient populations, including seniors and disabled adults, in need of care monitoring and assistance performing activities of daily living.
Slide 15: Simplura Acquisition — Announced Sept. 2020
SIMPLURA ACQUISITION — ANNOUNCED SEPT. 2020 * Immediately accretive before synergies © Simplura’s differentiators: — High customer retention rates — Low employee turnover vs. industry average — Large scale in existing markets — Above-average margin profile — Long-term patient-caregiver relationships
Slide 16: Significantly Expands Addressable Market in a Large and High-Growth Adjacency
SIGNIFICANTLY EXPANDS ADDRESSABLE MARKET IN A LARGE AND HIGH-GROWTH ADJACENCY Add “$558 for Personal Care Services Market? Core NEMT Market” $8.0B Add ~$4B for Medicare Advantage Growth (potential NEMT benefit expansion and enrollment increases over the next decade) $4.3B Existing U.S. NEMT Market (
Slide 17: Simplura Provides a New Growth Platform in Highly Fragmented Industry
SIMPLURA PROVIDES A NEW GROWTH PLATFORM IN HIGHLY FRAGMENTED INDUSTRY © >18,000 licensed U.S. home and community services agencies ¢ Top three players, including Simplura, make up <5% of market ¢ Trend towards narrowing of provider networks ¢ Industry consolidation expected to accelerate ¢ Simplura
Slide 18: ModivCare Has Multiple Growth Levers
MODIVCARE HAS MULTIPLE GROWTH LEVERS a Deliver on organic growth pillars a Execute on Simplura growth pathways — Strategically acquisitive — Existing market growth — Managed care penetration — New markets and programs Deepen payor relationships by creating a “one-stop shop” for Social Determinants o
Slide 19: Matrix Medical
MATRIX MEDICAL
Slide 20: Potential to Unlock Value from Matrix
POTENTIAL TO UNLOCK VALUE FROM MATRIX * We own a 43.6% minority stake in Matrix Medical Network $103 mm $255mm 7119/30/20 | 9140mm Net Debt Adj. EBITDA? | Book Value 9/30/20 9/30/20 © Matrix represents additional “hidden” value not reflected in Providence’s reported adjusted EBITDA ®Matrix Medical N
Slide 21: ModivCare Investment Highlights
MODIVCARE INVESTMENT HIGHLIGHTS Strong Competitive Advantages Developed over 20+ Years ) New Leadership with a Track Record of Operational Excellence ) Launched Six-Pillar Strategy to Drive Transformational Growth ) Clear Market Leader in Expanding NEMT Industry with Adjacent Opportunities ) Long-Ta
Slide 22: Appendix
APPENDIX
Slide 23: Creating Value Through Smart Capital Allocation
CREATING VALUE THROUGH SMART CAPITAL ALLOCATION Conversion of Series A Preferred Share Buyback Authorization Firsttranche+ conversion: ~$80 mm Total stock repurchased: ~$10 mm ($52.06 per share avg.) Acquisition of National MedTrans Agreement to Acquire Simplura Purchase Purchase price: price: ~$80
Slide 24: Matrix — Illustrative Valuation
MATRIX — ILLUSTRATIVE VALUATION DIFFERENT CAPITAL STRUCTURE THAN PROVIDENCE ° Legacy risk adjustment models consistently trade at EBITDA multiples of 10x-12x * New risk- and value-based models similar to Matrix are obtaining EBITDA multiples greater than 12x $Millions Illustrative Sceni LTM Adjusted
Slide 25: Simplura - Tailwinds Supporting Growth
SIMPLURA - TAILWINDS SUPPORTING GROWTH Daily Average Number of U.S. Population 65+ Years Old U.S. Population (millions) Turning 65 Years Old (thousands) Percent of Baby Boomers Begin 198 43 96 1 oy ss oss 8 1 1 1 1 ane 'aet ous ut a ean as a 2016 2020» 2030» «208020802060 Well Positioned for Value-B
Slide 26: NEMT 2020 Financial Performance
NEMT 2020 FINANCIAL PERFORMANCE $ Millions 2 172% 4a% a1 '20 a2 '20 93 '20 a1 '20 a2 '20 93 '20 —— 44). EBITDA Margin Free Cash Flow!) Gross Profit?) 98.6% = es ae $367.3 a1 '20 a2 '20 93 '20 a1 '20 a2 '20 93 '20 —— FoF Conversion Grose Marin (2) Re pe ti cae espace so MODIVCARE INC. //26
Slide 27: Simplura Historical Financial Performance
SIMPLURA HISTORICAL FINANCIAL PERFORMANCE $ Millions 12.7% 7 = LF 2018 2018 vp @/s0/z0 2018 2019 70 6/30/20 —— 44}. EBITDA Margin 38.0% 243% 246% 12% oe 3 2018 2019 YTD 6/30/20 2018 2019 YTD 6/30/20 ee —Sassinan (1) Defined as Adjusted EBITDA less Cape MODIVCARE INC. //27
Slide 28: NEMT Adjusted EBITDA and Free Cash Flow Reconciliations
NEMT ADJUSTED EBITDA AND FREE CASH FLOW RECONCILIATIONS EES Revenue Income from Cont Ops Interest Expense, Net Income Tax Provision Depreciation and Amortization EBITDA $ COVID-19 related costs Asset Impairment Transaction Expense Restructuring and Related Expense Equity in Net Loss/(Gain) of Invest
Slide 29: Simplura Adjusted EBITDA and Free Cash Flow Reconciliations
SIMPLURA ADJUSTED EBITDA AND FREE CASH FLOW RECONCILIATIONS See Revenue 390.9 $ 467.2 $ 2333 Net Income (Loss) (3.4) 45 (5.9) Interest Expense, Net 24.5 28.0 13.9 Income Tax Provision 2.0 2.6 07 Depreciation and Amortization 18.1 19.7 10.2 EBITDA $ 412 $ 548 $ 189 COVID-19 related costs - - 17 Manag
Slide 30: Adjusted EBITDA Reconciliation (Matrix)
ADJUSTED EBITDA RECONCILIATION (MATRIX) FYE ) | $Millions 2019 AEE ae aoe 2020 Revenue $ 275A § 357.3 208 $ 22795 717 $ 1407 Net (Loss) Income (694) (30.4) (15.1) 23.9 (69) 24 Interest Expense, Net 249 21.2 19.0 15.3 62 45 Income Tax (Benefit) Provision (16.5) (2.2) (45) 99 (20) 96 Depreciation and
Slide 31: IR Contact
IR CONTACT (—7_Q THe EQUITY GROUP Kalle Ahl, CFA (212) 836-9614 kahl@equityny.com MODIVCARE ING. //31